Gliosarcoma - 23 Studies Found

Active, not recruiting : DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
: Glioblastoma or Gliosarcoma
: 2014-07-20
:
  • Drug: Single intratumoral injection of DNX-2401

Completed : Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
:
  • Glioblastoma
  • Gliosarcoma

: 2008-01-29
: Drug: Avastin and Temozolomide This is Phase II study with the combination of Avastin & Temozolomide
Withdrawn : Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
:
  • Glioblastoma
  • Gliosarcoma

: 2015-11-04
:
  • Drug: Temozolomide

Completed : Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
:
  • Glioblastoma
  • Gliosarcoma

: 2008-08-12
:
  • Drug: Temozolomide

Completed : Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
:
  • Glioblastoma
  • Gliosarcoma

: 2007-09-04
:
  • Drug: Bevacizumab Patients are
Recruiting : NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
:
  • Gliosarcoma
  • Recurrent Glioblastoma

: 2017-01-11
:
  • Other: Laboratory Biomarker Analysis

Completed : Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
:
  • Glioblastoma
  • Glioblastoma Multiforme
  • : 2006-11-17
    :
    • Drug: enzastaurin Phase 1 - 25
Completed : Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
:
  • Glioblastoma Multiforme
  • GBM
  • Gliosarc
    : 2010-05-12
    : Drug: AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) IV AR-67 administered once daily for 5 day
Completed : Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
:
  • Glioblastoma
  • Gliosarcoma
  • Brai
    : 2008-01-10
    :
    • Drug: Avastin Avastin will be

Recruiting : BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab
:
  • Gliosarcoma
  • Recurrent Glioblastoma

: 2017-01-05
:
  • Other: Laboratory Biomarker Analysis

Next >>>